tagNames

investingSchoolPageQuery

InvestingSchoolQuery

feedContent

query investingSchoolPageQuery(
  $tagNames: [String!]
) {
  ...InvestingSchoolQuery_41MfQ6
}

fragment AuthorList on Content {
  __isContent: __typename
  id
  authors {
    __typename
    id
    name
    pageUrl
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment GeneralFeed_data_3brcg9 on Query {
  generalFeed: feedContent(first: 20, filter: {tagNames: $tagNames}) {
    edges {
      node {
        __typename
        id
        ...Teaser_content
        ...TeaserCompact_content
      }
      cursor
    }
    pageInfo {
      endCursor
      hasNextPage
    }
  }
}

fragment InvestingSchoolQuery_41MfQ6 on Query {
  ...GeneralFeed_data_3brcg9
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment TeaserCompact_content on Content {
  __isContent: __typename
  __typename
  id
  type
  title
  createdAt
  isPremium
  pageUrl
  lang
  companies {
    ...CompanyTagList
    id
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
  ...AuthorList
}

fragment Teaser_content on Content {
  __isContent: __typename
  __typename
  id
  type
  title
  createdAt
  pageUrl
  imgUrl
  isPremium
  lang
  companies {
    ...CompanyTagList
    id
  }
  publishers {
    imgUrl
  }
  authors {
    __typename
    id
  }
  ... on AnalystComment {
    preview
  }
  ... on Article {
    preview
  }
  ... on CompanyReport {
    preview
  }
  ... on ThirdPartyCompanyReport {
    preview
  }
  ... on QA {
    preview
  }
  ... on Video {
    preview
    liveTime
    videoDuration
  }
  ... on Webcast {
    preview
    liveTime
  }
  ...AuthorList
  ...Reactions
}


filter

first

edges

pageInfo

Karoliina Loikkanen

CSRD reporting from a stock picker’s perspective: Double materiality assessment

What a stock picker should understand about the new mandatory corporate sustainability (CSRD) reports, part 1.

Antti Siltanen

Faron Pharmaceuticals

Herantis Pharma

Orion

Modulight

Drug development investment: Value creation through M&As and licensing agreements

Mendus

Probabilities of success in drug development

Clinical phases of drug development

Investing school

CSRD reporting from a stock picker’s perspective: Double materiality assessment

What a stock picker should understand about the new mandatory corporate sustainability (CSRD) reports, part 1.

Drug development investment: Value creation through M&As and licensing agreements

Join Inderes community

FREE account

PREMIUM account

Probabilities of success in drug development

Clinical phases of drug development